1. Figure 2 Expression of complement activation products in renal samples
from patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)
Figure 2 | Expression of complement activation products in renal samples from patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). a–c | Immunohistochemistry staining of Bb, C3d and C5b–9 in the glomerulus of a patient with AAV. d–f | Immunohistochemistry staining of Bb, C3d and C5b-9 in the glomerulus of a normal control. g–i | Immunohistochemistry staining of Bb, C3d and C5b-9 in the small vessel wall of a patient with AAV. j–l | Immunohistochemistry staining of Bb, C3d and C5b–C9 in the small vessel wall of a normal control. Arrows indicate the small vessel. Permission obtained from American Society of Nephrology. Gou, S-J. et al. Clin. J. Am. Soc. Nephrol –1891 (2013).
Permission obtained from American Society of Nephrology. Gou, S-J. et al. Clin. J. Am. Soc. Nephrol –1891 (2013).
Chen, M. et al. (2017) Complement in ANCA-associated vasculitis: mechanisms and implications for management
Nat. Rev. Nephrol. doi: /nrneph